CG Structure · 2025
In this section23 topics
- Board Composition9 items
- Board of Directors1 item
- Board Meetings & Remuneration6 items
- Directors Who Left During the Year1 item
- Balance of Power Between the Board and Management3 items
- Board Roles, Duties and Charter3 items
- Other Board Governance Matters1 item
- Audit Committee5 items
- Executive Committee5 items
- Executives1 item
- Executive Remuneration3 items
- Remuneration Policy3 items
- Employees2 items
- Employee Remuneration1 item
- Provident Fund5 items
- Policy for Employees Not in the Provident Fund4 items
- Auditors and Audit Fees5 items
- Company Secretary and Other Assigned Persons5 items
- Investor Relations Contact3 items
- Representatives in Thailand (Foreign Companies)1 item
- Audit Committee Members Who Left During the Year1 item
- Executive Committee Members Who Left During the Year1 item
- Other Subcommittees — Members Who Left During the Year1 item
Board Composition
Board Composition — Introduction
The Board of Directors shall have an appropriate number of directors for the size of the business. As of December 31, 2025, the Company had a Board of Directors of 8 members, consisting of 4 executive directors and 4 non-executive directors (of which 4 are independent directors, which is more than 1 in 3 of the total number of directors, thus representing an appropriate balance of executive directors).
Independent Directors represent 50 percent of the Board of Directors. The Chairman of the Board is an Independent Director, and there are 2 female Independent Directors. The qualifications of the Independent Directors meet the criteria set by the Securities and Exchange Commission.
The Board of Directors comprises directors with diverse qualifications in education, gender, age, professional skills, experience, and expertise beneficial to the company (Board Diversity), as well as a diverse range of skills (Board Skill Matrix) necessary and appropriate for the business operation.

Board of Directors Meeting
The Company has a policy that the Board of Directors must hold a meeting at least 3 times a month. The Board of Directors meeting schedule is set in advance throughout the year and notified to each director in the third quarter of each year to allow directors to manage their time appropriately. Each meeting has a clearly defined agenda, and a notice of meeting and meeting documents are sent to the Board of Directors at least 7 days before the meeting date to allow the Board of Directors sufficient time to review the information before attending the meeting. Meetings are generally scheduled on the Saturday of the first week of February, May, August, and November, and there may be changes or additional Board meetings scheduled as appropriate.
For a Board of Directors’ meeting, a quorum shall be constituted by the presence of not less than two-thirds of the total number of directors. Likewise, resolutions of the Board shall be passed only when not less than two-thirds of the total number of directors are present at the meeting.
In considering various matters, the Chairman of the Board, who presides over the meeting, allocates sufficient time for the meeting and allows directors to express their opinions freely. Resolutions of the Board of Directors meeting shall be decided by a majority vote, with one vote for each director. All directors should have an attendance rate of at least 75 percent of all meetings throughout the year. The Board of Directors shall appoint the company secretary to record the minutes of the meeting and keep the minutes of the meeting approved by the Board of Directors.
Term of Office
The Company has a policy of setting the term of office of directors for 3 years per term. Each director can hold a position in no more than 5 listed companies. The Board of Directors does not specify the term of office of directors, independent directors, and subcommittees but considers their knowledge and ability to continue serving as directors.
Within 3 years, one-third (1/3) of the Board of Directors, or the closest number to one-third, must retire. The retiring directors may be re-elected for another term. The term of office shall be counted from the date of appointment until the date of the Annual General Meeting of Shareholders.
Total Number of Directors
8
Male Directors
3
Female Directors
5
Independent Directors
4
Non-executive Directors
4
Non-executive Directors Who Are Not Independent
0
Executive Directors
4
Total Board Meetings Held
7
Board of Directors
Directors
| Title | Title — Please Specify | First Name | Last Name | Gender | Year of Birth | Nationality | Resident in Thailand? | Position | Executive or Non-executive | Independent Director? | Director Type | Appointment Date | Authorised to Sign? | Related to Another Director or Executive? | Any Legal Violation in the Past 5 Years? | Highest Education | Field of Study | Field of Study — Please Specify | Skills & Expertise | Director Training | Attended Director Training? | Director Accreditation Program (DAP)? | Director Certification Program (DCP)? | Board Meetings Held | Board Meetings Attended | AGMs Held | AGMs Attended | Meeting Allowance (Baht) | Other Remuneration (Baht) | Total Remuneration (Baht) | Remuneration from Subsidiaries (Baht) | Non-monetary Remuneration | Shares Held | Shareholding (%) | Shares Held by Related Persons (s.59) | Shareholding by Related Persons (s.59, %) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| other | Dr. | APIROM | VEJABHUTI | F | 1,949 | 643 · Description: Thailand | Y | Chairman of the board | Non-executive | Y | Existing director | 2016-03-31T00:00 | N | N | N | Bachelor's degree | Medicine | 134 · Description: Health Care Services · 265 · Description: Governance/ Compliance · 163 · Description: Leadership · 156 · Description: Negotiation · 147 · Description: Sustainability | 1734 · Year: 2025 · Description: Financial Statements for Directors (FSD) · 1740 · Year: 2025 · Description: The Board’s Role in Mergers and Acquisitions (BMA) · 1730 · Year: 2016 · Description: Director Accreditation Program (DAP) · 1731 · Year: 2017 · Description: Director Certification Program (DCP) · 2021 · Description: Wellness and Healthcare Business Opportunity for Executives (WHB), ASEAN Institute for Health Development, Mahidol University, class 1 · 2020 · Description: Advanced Master of Management Program , Graduate School of Public Administration, National Institute of Development Administration, class 5 · 2025 · Description: SET Insight: ID & AC Focus for Growth and Sustainability in the Capital Market | Y | Y | Y | 7 | 7 | 1 | 1 | 112,000 | 95,400 | 207,400 | 100,000 | 0 | |||||
| Mrs. | SOONTHREE | CHANLONGBUTRA | F | 1,959 | 643 · Description: Thailand | Y | Director | Executive | Continuing director (Full term of directorship and being re-appointed as a director) | 2016-03-31T00:00 | Y | Y | N | Honorary degree | Management | 142 · Description: Marketing · 156 · Description: Negotiation · 163 · Description: Leadership · 164 · Description: Strategic Management · 1683 · Description: Business Administration | 1730 · Year: 2016 · Description: Director Accreditation Program (DAP) · 1731 · Year: 2017 · Description: Director Certification Program (DCP) · 2022 · Description: Thailand Insurance Super Leadership, Office of Insurance Commission, class 2 · 2016 · Description: Public Economics Management for Executives, King Prajadhipok's Institute, class 14 · 2014 · Description: Good Governance for Medical Executives, King Prajadhipok's Institute · 2018 · Description: OIC Advanced Insurance, Office of Insurance Commission, class 8 · 2016 · Description: Advanced Security Management Program, The Association of National Defence College of Thailand Under The Royal Patronage of His Majesty, class 8 · 2024 · Description: Moral Leaders Community Towards Sustainable Development Center for Morality Promotion (CMP) Public Organization, class 1 · 2024 · Description: Delivering Better Urban Practices, Navamindradhiraj University · 2024 · Description: Medical Hub Executive Program (MEP), Department of Health Services Support Foundation, class 1 · 2024 · Description: Super Legal Business Administration Leadership Program (Super LBA) Dhurakij Pundit, class 1 · 2023 · Description: Health Promotion and Prevention Program (HPP), Association of Surgical Oncologist (Thaialnd) A.S.O.T, class 1 · 2023 · Description: Tourism Management Program for Executives (TME4), TAT Academy, class 4 · 2023 · Description: Wellness & Healthcare Business Opportunity Program for Executive, Mahidol University · 2022 · Description: IT Bar 2022, Central Intellectual Property and Internation Trade Court · 2021 · Description: Health Innovation Digital Age (HIDA), Suan Sunandha Rajabhat University, class 1 · 2020 · Description: Executive Energy Program (EEP), The federation of Thai Industries, class 6 · 2019 · Description: Chief Transformation Officer (CTO), mai · 2019 · Description: Thai-Chinese Leadership Studies, Huachiew Chalermpakiet University, class 2 · 2025 · Description: Advanced Master of Management Program , Graduate School of Public Administration, National Institute of Development Administration, class 13 · 2025 · Description: Executive Program on Metropolitan Development, Navamindradhiraj University, class 13 · 2025 · Description: Health Ambassador, Chulabhorn Royal Academy, class 6 · 2025 · Description: Wellness Business and Beyond (WBB), Sukhabha Pisit Institue of Preventive Medicine and Wellness, class 3 · 2018 · Description: Capital Market Academy, class 26 | Y | Y | Y | 7 | 7 | 1 | 1 | 0 | 0 | 0 | 0 | 64,546,700 | 20.96 | 66,000,000 | 21.43 | ||||
| Mr. | MANIT | WONGPRISANLAK | M | 1,972 | 643 · Description: Thailand | Y | Director | Executive | Existing director | 2016-03-31T00:00 | Y | N | N | Bachelor's degree | Business Administration | 148 · Description: Procurement · 156 · Description: Negotiation · 164 · Description: Strategic Management · 1683 · Description: Business Administration · 117 · Description: Personal Products & Pharmaceuticals | 1731 · Year: 2016 · Description: Director Certification Program (DCP) · 1730 · Year: 2024 · Description: Director Accreditation Program (DAP) · 1735 · Year: 2026 · Description: Risk Management Program for Corporate Leaders (RCL) | N | Y | Y | 7 | 6 | 1 | 1 | 0 | 0 | 0 | 0 | ||||||||
| Ms. | PRANGCHAI | CHANLONGBUTRA | F | 1,990 | 643 · Description: Thailand | Y | Director | Executive | Existing director | 2016-03-31T00:00 | Y | Y | N | Master's degree | Business Administration | 143 · Description: Accounting · 144 · Description: Finance · 1683 · Description: Business Administration · 166 · Description: Audit | 1730 · Year: 2016 · Description: Director Accreditation Program (DAP) · 1731 · Year: 2018 · Description: Director Certification Program (DCP) · 2022 · Description: IR in Action, mai Listed Company Association · 2022 · Description: TLCA Executive Development Program 2021 : Building Transformational Leaders, Thai Listed Companies Association, · 2019 · Description: TLCA CFO Professional Development Program “Automation & RPA (Robot Process Automation) for Accounting , Thai Listed Companies Assocaition · 2024 · Description: TFRS for the year 68 Summary of Accounting Standards and Financial Reporting Standards, N Y C Management Co., Ltd., · 2025 · Description: Accountants and Sustainability Disclosure under Current Requirements and IFRS S1 and IFRS S2 / Carbon Credit Accounting.” | Y | Y | Y | 7 | 7 | 1 | 1 | 0 | 0 | 0 | 0 | 22,000,000 | 7.14 | ||||||
| other | Dr. | LACKANA | LEELAYOUTHAYOTIN | F | 1,953 | 643 · Description: Thailand | Y | Director | Non-executive | Y | Existing director | 2016-03-31T00:00 | N | N | N | Doctoral degree | Business Administration | 142 · Description: Marketing · 152 · Description: Data Analysis · 155 · Description: Brand Management · 112 · Description: Economics · 165 · Description: Risk Management | 1727 · Year: 2018 · Description: Advanced Audit Committee Program (AACP) · 1731 · Year: 2016 · Description: Director Certification Program (DCP) · 2018 · Description: TLCA Leadership Development Program, International Institute for Management Development (IMD) · 2016 · Description: Corporate Governance for Directors and Senior Executives of State Enterprises and Public Organizations (PDI), King Prajadhipok’s Institute, class 15 · 2025 · Description: Seminar: “In-Depth Insights into Expectations for the Roles and Proper Performance of the Audit Committee (AC) and the Chief Audit Executive (CAE), SET and the Federation of Accounting Professions · 1735 · Year: 2025 · Description: Risk Management Program for Corporate Leaders (RCL) | Y | Y | Y | 7 | 7 | 1 | 1 | 77,000 | 95,400 | 172,400 | 0 | ||||||
| Mr. | JUMPHOT | CHUASAI | M | 1,954 | 643 · Description: Thailand | Y | Director | Non-executive | Y | Existing director | 2016-03-31T00:00 | N | N | N | Master's degree | other | International Relations | 146 · Description: Human Resource Management · 156 · Description: Negotiation · 164 · Description: Strategic Management · 167 · Description: Internal Control · 265 · Description: Governance/ Compliance | 1730 · Year: 2016 · Description: Director Accreditation Program (DAP) · 1731 · Year: 2018 · Description: Director Certification Program (DCP) · 1734 · Year: 2022 · Description: Financial Statements for Directors (FSD) · 2025 · Description: SET Insight: ID & AC Focus for Growth and Sustainability in the Capital Market · 2025 · Description: 2025 Annual Audit Committee Seminar — In the Winds of Change: Adapting to a Changing World, EY · 2023 · Description: Seminar on Financial Statement Fraud, Economic Updates, ESG Direction, and Carbon Emissions, EY · 2023 · Description: Seminar: Strong Listed Companies Program, SEC | Y | Y | Y | 7 | 7 | 1 | 1 | 77,000 | 95,400 | 172,400 | 0 | ||||||
| other | Dr. | ANIWAT | SIRIDEJVARAVONG | M | 1,971 | 643 · Description: Thailand | Y | Director | Non-executive | Y | Newly appointed director to replace the ex-director | 2025-05-10T00:00 | N | N | N | Doctoral degree | other | Organization Management | 140 · Description: Information & Communication Technology · 1683 · Description: Business Administration · 150 · Description: IT Management · 142 · Description: Marketing · 165 · Description: Risk Management | 1730 · Year: 2025 · Description: Director Accreditation Program (DAP) | Y | Y | N | 5 | 5 | 0 | 0 | 55,000 | 0 | 55,000 | 0 | |||||
| Ms. | PRAE | CHANLONGBUTRA | F | 1,987 | 643 · Description: Thailand | Y | Director | Executive | Newly appointed director to replace the ex-director | 2019-04-24T00:00 | Y | Y | N | Master's degree | Business Administration | 142 · Description: Marketing · 155 · Description: Brand Management · 151 · Description: Data Management · 152 · Description: Data Analysis | 1730 · Year: 2021 · Description: Director Accreditation Program (DAP) | N | Y | N | 3 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 22,435,070 | 7.28 |
Board Meetings & Remuneration
Board Meetings — Introduction
As of December 31, 2025, the company has 8 directors, comprising 4 executive directors and 4 independent directors.
The Chairman is not the same person as the Chief Executive Officer to ensure a clear separation of roles and responsibilities. All four appointed independent directors are independent from the management and major shareholders of the company, with Miss Supattra Kamkaew serving as the Company Secretary.
The authorized signatories for/to bind the company are Mrs. Soonthree Chanlongbutra, Miss Prangchai Chanlongbutra, Miss Prae Chanlongbutra, or Mr. Manit Wongprisanlak. Any two of these four persons shall jointly sign and affix the company's seal.
Separation of the positions of Chairman and Chief Executive Officer.
The company has clearly separated the roles and responsibilities of the Chairman and the Chief Executive Officer, and they are not the same person. The Chairman is an independent director, responsible for leading the Board of Directors and overseeing the efficient performance of the Board, while the Chief Executive Officer is responsible for controlling the company's operations.
Scope of authority of the Chairman.
Chair meetings of the Board of Directors and shareholders' meetings.
Control meetings to be efficient and in accordance with the company's regulations, supporting and providing opportunities for directors to express their opinions independently.
Oversee the efficient performance of the Board of Directors, ensuring duties are carried out to the fullest extent of their responsibilities and in accordance with good corporate governance principles.
Support coordination and foster good relationships between the Board of Directors and management.
Scope of authority and responsibilities of the Chief Executive Officer.
The Board of Directors' Meeting No. 1/2559 (the first after conversion to a public limited company) on March 31, 2016, resolved to define the scope and authority of the Chief Executive Officer as follows:
Control business operations, plan operational strategies, and manage the company's daily affairs.
Decide on important company matters, define the company's mission, objectives, guidelines, and policies, including controlling management in various departments.
Has the authority to command, communicate, instruct, and sign legal acts, contracts, order documents, and any notices as specified in the operational authority manual.
Has the authority to hire, appoint, transfer personnel as deemed appropriate, as well as define the scope of duties and suitable remuneration, and has the authority to dismiss or terminate employees at various levels as specified in the operational authority manual.
Has the authority to define commercial terms for the benefit of the company.
Consider investments in new businesses or the cessation of businesses, to be presented to the Executive Board and/or the Board of Directors.
Approve and appoint various consultants necessary for operations.
Perform any actions as assigned by the Executive Board and/or the Board of Directors.
Furthermore, the aforementioned delegation of duties and responsibilities to the Chief Executive Officer requires the Chief Executive Officer to comply with the terms and agendas approved by the Board of Directors, and shall not include the power and/or sub-delegation of authority to approve any transaction in which he/she, or the sub-delegate, or any person who may have a conflict of interest (as defined in the Capital Market Supervisory Board's notification), has a vested interest or any other conflict of interest with the company. The approval of such transactions must be submitted to the Board of Directors' meeting and/or the shareholders' meeting (as the case may be) for consideration and approval, as stipulated by the company's articles of association or relevant laws.
Scope of authority and responsibilities of the Chief Executive Officer.
The Board of Directors' Meeting No. 1/2559 (the first after conversion to a public limited company) on March 31, 2016, resolved to define the scope and authority of the Chief Executive Officer as follows:
Has the authority to control the company's operations to be in accordance with the policies set by the Board of Directors or the Executive Board, and to report operational results to the Board of Directors or the Executive Board, respectively.
Consider the annual budget allocation prepared by the management, to be presented to the Executive Board for approval, and control the annual budget expenditure of each department.
Regularly review and evaluate the company's operations to prevent risks from various factors, whether internal or external to the company.
Has the authority to issue orders, regulations, announcements, and memos to ensure operations comply with the policies of the Board of Directors or the Executive Board, or for the benefit of the company.
Has the authority to consider and approve procurement and expenditures related to the company's normal operations, as well as operating expenses, selling and administrative expenses, and capital expenditures, in accordance with the budget approved by the Board of Directors or the Executive Board, within the defined approval authority.
Consider encumbering the company's rights and assets with any individual, company, shop, or financial institution, to be presented to the Executive Board for approval.
Review the company’s profits and losses and propose the payment of interim or annual dividends for approval by the Board of Directors.
Perform any actions to support the company's operations as authorized by the Board of Directors, in accordance with the Board's policies.
However, the aforementioned delegation of authority to the Chief Executive Officer shall not include the power for the Chief Executive Officer to approve transactions in which he/she, or any person who may have a conflict of interest, has a vested interest, or may have any other conflict of interest as per the company's regulations and as prescribed by the Securities and Exchange Commission.
Any other actions beyond those mentioned above cannot be performed by the Chairman and Chief Executive Officer, unless specifically assigned by the Board of Directors meeting on a case-by-case basis.
Furthermore, the delegation of authority for important matters is granted by the Board of Directors, who consider and delegate authority to individuals or groups of authorized persons. They may further delegate authority to employees as deemed appropriate by the Board of Directors or the Chief Executive Officer, with significant approval powers as specified in the attachment no. 10.
Date of the Annual General Meeting
2024-04-18T00:00
Was an Extraordinary General Meeting Held?
No
Board Meeting Allowance (Baht)
332000.0
Other Board Remuneration (Baht)
381600.0
Total Board Remuneration (Baht)
713600.0
Directors Who Left During the Year
Directors Who Left During the Year
| Title | Title — Please Specify | First Name | Last Name | Gender | Year of Birth | Nationality | Resident in Thailand? | Position | Executive or Non-executive | Independent Director? | Appointment Date | Date of Leaving | Authorised to Sign? | Related to Another Director or Executive? | Any Legal Violation in the Past 5 Years? | Replaced By — First Name | Replaced By — Last Name | Date the Replacement Took Office | Highest Education | Field of Study | Director Training | Attended Director Training? | Director Accreditation Program (DAP)? | Director Certification Program (DCP)? | Board Meetings Held | Board Meetings Attended | AGMs Held | AGMs Attended | Meeting Allowance (Baht) | Other Remuneration (Baht) | Total Remuneration (Baht) | Non-monetary Remuneration | Shares Held | Shareholding (%) | Shares Held by Related Persons (s.59) | Shareholding by Related Persons (s.59, %) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| other | Doctor | SUPAPONG | CHANLONGBUTRA | M | 1,958 | 643 · Description: Thailand | Y | Director | Executive | 2016-03-31T00:00 | 2025-08-09T00:00 | N | Y | N | PRAE | CHANLONGBUTRA | 2025-08-09T00:00 | Bachelor's degree | Medicine | 1730 · Year: 2015 · Description: Director Accreditation Program (DAP) | N | Y | N | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 66,000,000 | 21.43 | 64,546,700 | 20.96 | |
| Mrs. | RATANA | ANUPASANANT | F | 1,955 | 643 · Description: Thailand | Y | Director | Non-executive | Y | 2016-03-31T00:00 | 2025-05-09T00:00 | N | N | N | ANIWAT | SIRIDEJVARAVONG | 2025-05-10T00:00 | Master's degree | Business Administration | 1739 · Year: 2019 · Description: Successful Formulation & Execution of Strategy (SFE) · 1737 · Year: 2018 · Description: Strategic Board Master Class (SBM) · 1733 · Year: 2017 · Description: Ethical Leadership Program (ELP) · 1727 · Year: 2017 · Description: Advanced Audit Committee Program (AACP) · 1735 · Year: 2017 · Description: Risk Management Program for Corporate Leaders (RCL) · 1730 · Year: 2016 · Description: Director Accreditation Program (DAP) · 1731 · Year: 2016 · Description: Director Certification Program (DCP) · 2018 · Description: Corporate Governance for Directors and Senior Executives of State Enterprises and Public Organizations (PDI), King Prajadhipok’s Institute, class 19 | Y | Y | Y | 1 | 1 | 1 | 1 | 11,000 | 95,400 | 106,400 | 0 | |||||
| Ms. | PRAE | CHANLONGBUTRA | F | 1,987 | 643 · Description: Thailand | Y | Director | Executive | 2019-04-24T00:00 | 2025-04-18T00:00 | Y | Y | N | Master's degree | Business Administration | 1730 · Year: 2021 · Description: Director Accreditation Program (DAP) | N | Y | N | 22,435,070 | 7.28 |
Balance of Power Between the Board and Management
Are There Measures Balancing the Board's and Management's Power?
Yes
Measures Balancing the Board's and Management's Power
The company has established a corporate governance structure that clearly separates the roles, duties, and responsibilities of the Chairman of the Board and the Chief Executive Officer (CEO), with the two positions held by different individuals. This separation strengthens checks and balances and promotes good corporate governance.
The Chairman of the Board is an Independent Director and serves as the leader of the Board, overseeing the effective and transparent performance of the Board’s duties in accordance with good corporate governance principles.
Meanwhile, the Chief Executive Officer is responsible for setting management policies and overseeing the company’s operations in line with the strategic plans and objectives approved by the Board of Directors.
Methods Used to Balance Power
| Method | Other — Please Specify |
|---|---|
| Other | Separation of the roles of Chairman of Board of Directors and Chief Executive Officer (CEO) |
Board Roles, Duties and Charter
Does the Company Have a Board Charter?
Yes
Content of the Board Charter
At the Board of Directors' Meeting No. 1/2024, the scope of authority, duties, and responsibilities of the Board of Directors were reviewed to comply with SEC. Nro. (Wor.) 35/2023 Re: Rehearsal of Understanding Regarding the Roles and Responsibilities of the Board of Directors, issued by the Securities and Exchange Commission (SEC).
1. Establish an effective, adequate, and appropriate internal control system.
• Ensure that there is an internal audit (IA) unit, whether in-house or outsourced, with sufficient knowledge and ability, independent from management, and reporting directly to the AC.
• If there is an expansion of business abroad, which may be a significant investment, ensure that there is an overall internal control system that can detect irregularities and prevent fraud. • Oversee that management has an appropriate and effective risk management system.
• Define the authority and level of approval for transactions and various operations related to the company's work to the appropriate person or group of persons and in accordance with relevant laws by preparing an authority manual and having it reviewed at least once a year to be appropriate for the changing business environment.
2. Monitor and track transactions that are acquisitions or disposals of assets with significant value (MT) and related party transactions (RPT), including fundraising transactions.
• Have a mechanism to appropriately check for reasonableness before conducting any transaction, such as considering whether to hire independent experts to provide opinions or encouraging scrutiny and consideration of transactions by working groups or subcommittees, including a mechanism to monitor and report on the progress of the transaction continuously.
• Have a system for disclosing transactions and business operations accurately, appropriately, completely, and equally to all investor groups. Have a system to control, monitor, and track the trading of securities by directors, executives, and those who may have access to material inside information.
• Ensure that there is a system to monitor and track related party transactions that may give rise to conflicts of interest.
• Consider approving the acquisition or disposal of the company's assets, except in cases where such transactions must be approved by the shareholders' meeting. In considering such approval, it shall comply with the announcements, regulations, and/or rules of the Stock Exchange of Thailand.
• Consider approving related party transactions, except in cases where such transactions must be approved by the shareholders' meeting. In considering such approval, it shall comply with the announcements, regulations, and/or rules related to the Stock Exchange of Thailand.
3. Communication to Shareholders
• Establish an investor relations department to communicate the company's information to stakeholders such as shareholders, investors, and analysts.
• Encourage the company to participate in the Opportunity Day for listed companies regularly at least once a year so that investors can monitor and understand the operating results or business operations that may change during the accounting year.
• Directors, executives, and auditors, especially the chairman of the audit committee, should attend the shareholders' meeting to clarify and answer questions.
• Ensure that the minutes of the shareholders' meeting are recorded completely, accurately, and without causing misunderstanding of the essence. 115 Part 2 Corporate Governance
• Give importance to the policy of overseeing the appropriate use of inside information.
• Be accountable to shareholders on a regular basis, operate in the best interests of shareholders, disclose material information to investors accurately, completely, with standards, and transparently.
4. Encourage the company to comply with the CG Code and participate in assessments by relevant agencies. • Ensure that directors, executives, and employees are aware of and comply with the established policies.
• Monitor, evaluate, and continuously improve the good corporate governance mechanism.
• Establish policies and procedures for handling complaints and whistleblowing on inappropriate conduct, including appropriate measures to protect whistleblowers.
5. Perform duties with responsibility, prudence, honesty, integrity, and in accordance with the law, the objectives, the company's articles of association, as well as the resolutions of the shareholders, and any other duties of the directors as stipulated in any announcements, regulations, acts, or other laws governing the company.
6. Consider approving the appointment of persons who are qualified and do not have prohibited characteristics as stipulated in the Public Limited Company Act B.E. 2535 and the Securities and Exchange Act, including announcements, regulations, and/or rules related to the position of director in the event that the position of director becomes vacant for reasons other than retirement by rotation.
7. Consider the appointment of subcommittees by selecting from the company's directors, executives, and/or employees, along with defining the scope of authority, duties, and responsibilities of the subcommittees.
8. Consider the appointment of independent directors and audit committees by considering the qualifications and prohibited characteristics of independent directors and audit committees in accordance with the Securities and Exchange Act, including announcements, regulations, and/or relevant rules of the Stock Exchange of Thailand, or propose to the shareholders' meeting for consideration and appointment as independent directors and audit committees of the company.
9. Consider determining and amending the names of directors who have the authority to bind the company.
10. Appoint any other person to conduct the business of the company under the supervision of the Board of Directors or may grant authority to such person to have the power and/or within such time as the Board of Directors deems appropriate, which the Board of Directors may revoke, extend, amend, or modify such authority.
11. Consider appointing a company secretary in accordance with the Securities and Exchange Act to be responsible for preparing, maintaining documents, and other matters as prescribed by the Capital Market Supervisory Board, and assisting in various activities of the Board of Directors and the company, such as meetings of the Board of Directors and shareholders, as well as providing advice to the Board of Directors and the company in conducting themselves and their business in accordance with relevant laws and regulations on a regular basis. In addition, ensure that the Board of Directors and the company disclose information accurately, completely, and transparently.
12. Consider approving the payment of interim dividends to shareholders when it is deemed that the company has sufficient profits to do so and report such dividend payment to the shareholders' meeting at the next shareholders' meeting.
13. Establish the company's vision, policies and operational direction, business strategies, annual budget, and supervise, monitor, and oversee the management to effectively and efficiently implement the established policies to maximize economic value for shareholders and sustainable growth, with an annual review of the vision and mission.
14. Evaluate the performance of the Chief Executive Officer and senior management and determine their compensation.
15. Determine the remuneration of directors.
16. Be responsible for the operating results and performance of the management with diligence and prudence in performing their duties.
17. Oversee the setting of clear and measurable business goals to be used as guidelines for setting operational goals, taking into account feasibility and reasonableness.
18. Consider and decide on material matters such as business policies and plans, large investment projects, management authority, acquisition or disposal of assets, and any other matters stipulated by law.
19. Provide a reliable accounting, financial reporting, and auditing system, including overseeing the process of assessing the adequacy of internal control.
20. Approve the proposed appointment of auditors and consider the annual audit fees for submission to the shareholders for approval. 116 Part 2 Corporate Governance
21. Report the Board of Directors' responsibilities in preparing the financial statements, presented in conjunction with the auditor's report in the annual report, and covering important matters in accordance with the best practice policy for the Board of Directors of listed companies on the Stock Exchange of Thailand.
22. Oversee the work of various subcommittees to comply with the established charter.
23. The Board of Directors should conduct a self-evaluation at least once a year.
24. Report the purchase-sale/holding of the company's securities to the Board of Directors' meeting.
25. Review and update the Board of Directors' charter at least once a year.
26. Report their shareholdings, those of their spouse and minor children in the company and its subsidiaries at the Board of Directors' meetings and must notify the company without delay in the following cases:
26.1 Have a direct or indirect interest in any contract made by the company during the accounting year. 26.2 Hold shares in the company and its subsidiaries. It is stipulated that directors who have or may have a conflict of interest or other conflict of interest with the company shall not be entitled to vote on such matters.
In addition, in the following cases, approval from both the Board of Directors' meeting and the shareholders' meeting must be obtained by a vote of not less than 3 out of 4 of the total votes of the shareholders present at the meeting and entitled to vote:
(a) The sale or transfer of all or a significant portion of the company's business to another person.
(b) The acquisition or transfer of the business of another private or public company to the company.
(c) Entering into, amending, or terminating a contract for the lease of all or a significant portion of the company's business, assigning any other person to manage the company's business, or merging with another person for the purpose of profit sharing.
(d) Amending the memorandum of association or articles of association of the company.
(e) Increasing or decreasing the registered capital of the company.
(f) Dissolution of the company.
(g) Issuance of debentures of the company.
(h) Merger of the company with another company.
(i) Any other matters stipulated under the provisions of the Securities and Exchange Act and/or the regulations of the Stock Exchange of Thailand that require approval from the shareholders' meeting with the aforementioned votes, such as the acquisition or disposal of assets, related party transactions, etc.
Term of Office of the Board of Directors
The Board of Directors, which is responsible for managing the company's business operations, shall have a term of office as stipulated in the company's articles of association, namely, at each annual general meeting of shareholders, one-third (1/3) of the directors at that time shall retire from office. If the number of directors cannot be divided equally into three parts, the number closest to one-third (1/3) shall retire. Retiring directors may be re-elected.
In the event that a vacancy on the Board of Directors occurs for reasons other than retirement by rotation, the Board of Directors shall elect a person who is qualified and does not have prohibited characteristics under the Public Limited Company Act and the Securities and Exchange Act to be a director at the next Board of Directors' meeting, unless the term of office of the outgoing director is less than two months (the resolution of the Board of Directors in such case must be passed by a vote of not less than three-fourths of the remaining directors). The person who becomes a director in replacement shall hold office only for the remaining term of the director whom he replaces.
Link to the Board Charter
https://www.technomedical.co.th/charter
Other Board Governance Matters
Board Governance Practices
| Practice | Yes / No |
|---|---|
| The chairman of the board and the highest-ranking executive are from the same person | N |
| The chairman of the board is an independent director | Y |
| The chairman of the board and the highest-ranking executive are from the same family | N |
| Chairman is a member of the executive board or taskforce | N |
| The company appoints at least one independent director to determine the agenda of the board of directors’ meeting | N |
Audit Committee
Audit Committee Charter
| Roles, Duties and Responsibilities | Type of Subcommittee | Link to the Charter |
|---|---|---|
1. Overseeing the Effectiveness, Adequacy, and Appropriateness of the Internal Control System
* Ensuring that the company has appropriate and effective internal control and internal audit systems.
* Providing recommendations for the appointment, transfer, and termination of the head of internal audit or other units responsible for internal audit, ensuring the internal audit unit's independence from management, possessing the necessary knowledge, abilities, understanding of business risks, and reporting directly to the Audit Committee.
* Recommending reviews or audits of any significant matters, and proposing improvements to the internal control system to the Board of Directors, in consultation with the external auditor and the internal audit manager.
* Collaborating with the internal audit unit in developing the internal control system audit plan and reviewing the company's internal audit plan based on generally accepted standards.
* Continuously and consistently reviewing and improving the internal control system of the group, both domestically and internationally, to detect irregularities and prevent fraud.
* Promoting channels for receiving complaints and whistleblowing on inappropriate internal conduct, including appropriate policies and procedures for handling complaints and protecting whistleblowers.
* In case of observations or deficiencies due to the lack of or non-compliance with the system and relevant regulations, the Audit Committee must raise concerns, inquire about the causes, and the scope of the audit from relevant parties to prevent damage to the company and shareholders.
2. Financial Reporting and Disclosure
* Considering, proposing, appointing, and terminating independent individuals as auditors, ensuring clear scope of work, independence, knowledge, and abilities, including recommending auditor remuneration to the Board of Directors, and attending meetings with the auditors without management present at least once a year.
* Monitoring and overseeing management in preparing financial statements within an appropriate timeframe to allow auditors and the Audit Committee sufficient time for review and timely disclosure.
* Investigating irregularities in financial statements, such as significant changes in figures or financial ratios.
* Reviewing the consistency of information in financial statements with other information, such as MD&A.
* Reviewing financial reporting and disclosures to ensure accuracy, reliability, and adequacy, in coordination with the external auditor and management responsible for preparing quarterly and annual financial reports.
3. Reviewing, Analyzing Impacts, Issues, and Establishing Preventive Measures
* Reporting to the SEC immediately upon receiving reports from auditors regarding suspicious conduct of directors, management, or persons responsible for the company's operations under Section 89/25 of the Securities and Exchange Act.
* Reviewing compliance with securities and exchange laws, Stock Exchange regulations, policies, rules, regulations, and other laws relevant to the company's business.
4. Monitoring Acquisitions or Disposals of Significant Assets (MT) and Related Party Transactions (RPT)
* Participating in the consideration and providing opinions on the reasonableness of transactions, details, substance of counterparties, returns, and associated risks, particularly legal aspects and impacts on financial position and performance.
* For transactions within management's approval authority, the Audit Committee must establish a system or mechanism for management to report transactions and analyze their reasonableness on an ongoing basis. For multiple transactions related to the same project, the Audit Committee must consider the reasonableness and nature of the project, including whether there is an intention to circumvent the criteria.
* In cases requiring expert opinions, the Audit Committee should provide support to ensure the effectiveness of the audit function.
* After transaction approval, the Audit Committee must monitor and inquire about the progress of the transaction, ensuring timely and appropriate disclosure and reporting to shareholders.
* Monitoring for overall irregularities and reporting to the SEC immediately if there are suspicions of inaccurate information or intentions to manipulate stock prices.
5. Monitoring the Use of Proceeds to Align with Disclosed Objectives
* Collaborating with the committee to review details related to the use of proceeds, such as project feasibility, investment appropriateness, and fundraising channels.
* Establishing mechanisms to oversee and monitor the proper and appropriate use of proceeds in accordance with disclosed objectives and reporting progress to shareholders.
6. Review and ensure that the company has an appropriate and effective risk management system.
7. Reporting the Audit Committee's Performance to the Board of Directors at Least Four Times a Year.
8. Preparing an Audit Committee Report for Disclosure in the Company's Annual Report. This report must be signed by the Audit Committee Chairman and include at least the following information:
(a) Opinion on the accuracy, completeness, and reliability of the company's financial statements.
(b) Opinion on the adequacy of the company's internal control system.
(c) Opinion on compliance with securities and exchange laws, Stock Exchange regulations, or laws related to the company's business.
(d) Opinion on the suitability of the auditor.
(e) Opinion on related party transactions or transactions with potential conflicts of interest.
(f) Number of Audit Committee meetings and attendance of each Audit Committee member.
(g) Overall opinions or observations received by the Audit Committee from performing its duties according to its charter.
(h) Other matters deemed relevant for shareholders and investors to be aware of, within the scope of duties and responsibilities assigned by the Board of Directors.
9. In Performing its Duties, the Audit Committee has the Authority to Invite Management, Executives, or Relevant Company Employees to Provide Opinions, Attend Meetings, or Submit Relevant Documents.
10. Having the Authority to Engage Consultants or External Parties, in Accordance with Company Regulations, to Provide Opinions or Advice When Necessary.
11. The Audit Committee Must Evaluate its Performance through Self-Assessment and Report the Results, Including Obstacles Encountered that May Hinder the Achievement of its Objectives, to the Board of Directors Annually.
12. Reviewing and Updating the Audit Committee Charter.
13. Performing Other Duties as Assigned by the Board of Directors Within the Scope of the Audit Committee's Duties and Responsibilities.
In performing the aforementioned duties, the Audit Committee is directly accountable to the Board of Directors. The Board of Directors remains responsible for the company's operations to external parties. All three Audit Committee members are independent directors who meet the qualifications outlined in Clause 16 of the Capital Market Supervisory Board's Notification No. TorChor. 28/2551.
Term of Office for Audit Committee Members
Audit Committee members serve a term of 3 years, with 1 year defined as the period between the Annual General Meeting of Shareholders in the year of appointment until the Annual General Meeting of Shareholders in the following year. Audit Committee members whose terms expire may be nominated and reappointed. In addition to the expiration of their term, Audit Committee members cease to hold office upon:
1. Death.
2. Resignation.
3. Disqualification as an Audit Committee member or according to the criteria of the Stock Exchange of Thailand.
4. Expiration of their term as a member of the Board of Directors.
An Audit Committee member who wishes to resign must submit a letter of resignation to the Chairman of the Board of Directors at least 1 month in advance. The Board of Directors will then approve the resignation. The company will notify the Stock Exchange of Thailand of the resignation, along with a copy of the resignation letter. If the entire Audit Committee resigns, the outgoing Audit Committee must remain in office until a new Audit Committee is appointed.
In the event of a vacancy on the Audit Committee due to reasons other than the expiration of the term, the Board of Directors must appoint a qualified individual to fill the vacancy within 90 days to maintain the required number of Audit Committee members. The appointed individual will serve the remaining term of the vacating Audit Committee member. | 3091 · Description: Audit of financial statements and internal controls | https://www.technomedical.co.th/charter-audit |
Audit Committee Members
| Title | Title — Please Specify | First Name | Last Name | Position | Gender | Year of Birth | Nationality | Resident in Thailand? | Appointment Date | Highest Education | Field of Study | Field of Study — Please Specify | Has Accounting or Financial Expertise? | Skills & Expertise | Meetings Held | Meetings Attended | Meeting Allowance (Baht) | Other Remuneration (Baht) | Total Remuneration (Baht) | Non-monetary Remuneration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| other | Dr. | LACKANA | LEELAYOUTHAYOTIN | Chairman of the audit committee | F | 1,953 | 643 · Description: Thailand | Y | 2016-03-31T00:00 | Doctoral degree | Business Administration | N | 142 · Description: Marketing · 152 · Description: Data Analysis · 155 · Description: Brand Management · 112 · Description: Economics · 165 · Description: Risk Management | 4 | 4 | 64,000 | 0 | 64,000 | 0 | |
| Mr. | JUMPHOT | CHUASAI | Audit committee | M | 1,954 | 643 · Description: Thailand | Y | 2016-03-31T00:00 | Master's degree | other | International Relations | N | 146 · Description: Human Resource Management · 156 · Description: Negotiation · 164 · Description: Strategic Management · 167 · Description: Internal Control · 265 · Description: Governance/ Compliance | 4 | 4 | 44,000 | 0 | 44,000 | 0 | |
| other | Dr. | ANIWAT | SIRIDEJVARAVONG | Audit committee | M | 1,971 | 643 · Description: Thailand | Y | 2025-05-10T00:00 | Doctoral degree | other | Organization Management | Y | 140 · Description: Information & Communication Technology · 1683 · Description: Business Administration · 150 · Description: IT Management · 142 · Description: Marketing · 165 · Description: Risk Management | 2 | 2 | 22,000 | 22,000 | 0 |
Audit Committee — Meeting Allowance (Baht)
141000.0
Audit Committee — Other Remuneration (Baht)
0.0
Audit Committee — Total Remuneration (Baht)
141000.0
Executive Committee
Executive Committee Charter
| Roles, Duties and Responsibilities | Type of Subcommittee | Link to the Charter |
|---|---|---|
1. Oversee the company's management in accordance with the policies set by the Board of Directors and report the performance to the Board of Directors. The Executive Committee meeting requires the attendance of at least half of the Executive Committee members. Resolutions of the Executive Committee must receive a majority vote of the members present, with such votes representing at least half of the total votes of the Executive Committee.
2. Consider and establish appropriate levels of authority and approval for each individual, ensuring the segregation of duties that may facilitate fraud. Define procedures and methods for conducting business with major shareholders, directors, executives, or related parties to prevent conflicts of interest. Present these to the Board of Directors for approval and ensure compliance with the approved principles and requirements.
3. Review the annual budget and budget disbursement procedures for submission to the Board of Directors. Oversee expenditures in accordance with the budget approved by the Board of Directors.
4. Consider and revise the company's business plan as appropriate for the benefit of the company.
5. Consider and approve investments and determine investment budgets within the scope of authority outlined in the Authorization Manual.
6. Consider and approve various contracts that bind the company, within the scope of authority outlined in the Authorization Manual.
7. Ensure the availability of sufficient and relevant company information to facilitate informed decision-making by the Board of Directors and shareholders. Ensure the preparation of reliable financial reports in accordance with good and transparent standards.
8. Review the company's profits and losses and propose annual dividend payments to the Board of Directors.
9. Consider new business ventures or business closures for proposal to the Board of Directors.
10. Ensure the establishment of procedures requiring employees to promptly report any unusual events, irregularities, or illegal acts to the Executive Committee. In the event that such events have a material impact, the Board of Directors must be informed for timely consideration and resolution.
11. Undertake any actions to support the aforementioned operations, as deemed appropriate by the Board of Directors, or as authorized by the Board of Directors.
12. Any proposals submitted to the Executive Committee meeting that receive a resolution and/or approval from the Executive Committee meeting must be reported to the Board of Directors at the next Board of Directors meeting.
The delegation of authority, duties, and responsibilities of the Executive Committee as mentioned above shall not include the authority and/or sub-delegation of authority to approve any transactions in which the Executive Committee members, their sub-delegates, or any person with a potential conflict of interest (as defined in the Notification of the Capital Market Supervisory Board) have any interest or benefit that conflicts with the company's interests. The approval of such transactions must be submitted to the Board of Directors meeting and/or the Shareholders' Meeting (as the case may be) for consideration and approval in accordance with the company's Articles of Association or relevant laws. | 3097 · Other name: Management Control · Description: Others | https://www.technomedical.co.th/charter-executive |
Executive Committee Members
| Title | First Name | Last Name | Position | Gender | Year of Birth | Nationality | Resident in Thailand? | Appointment Date | Highest Education | Field of Study | Meetings Held | Meetings Attended | Meeting Allowance (Baht) | Other Remuneration (Baht) | Total Remuneration (Baht) | Non-monetary Remuneration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mrs. | SOONTHREE | CHANLONGBUTRA | Chairman of the executive committee | F | 1,959 | 643 · Description: Thailand | Y | 2016-03-31T00:00 | Honorary degree | Management | 12 | 12 | 0 | 0 | 0 | 0 |
| Ms. | PRANGCHAI | CHANLONGBUTRA | Member of the executive committee | F | 1,990 | 643 · Description: Thailand | Y | 2018-02-24T00:00 | Master's degree | Business Administration | 12 | 12 | 0 | 0 | 0 | 0 |
| Mr. | MANIT | WONGPRISANLAK | Member of the executive committee | M | 1,972 | 643 · Description: Thailand | Y | 2016-03-31T00:00 | Bachelor's degree | Business Administration | 12 | 11 | 0 | 0 | 0 | 0 |
| Ms. | PRAE | CHANLONGBUTRA | Member of the executive committee | F | 1,987 | 643 · Description: Thailand | Y | 2025-08-09T00:00 | Master's degree | Business Administration | 7 | 5 | 0 | 0 | 0 | 0 |
Executive Committee — Meeting Allowance (Baht)
0.0
Executive Committee — Other Remuneration (Baht)
0.0
Executive Committee — Total Remuneration (Baht)
0.0
Executives
Executives
| Title | Title — Please Specify | First Name | Last Name | Position | Gender | Year of Birth | Nationality | Resident in Thailand? | Appointment Date | Highest Education | Field of Study | Skills & Expertise | Is the Highest-ranking Executive? | Is the Highest-ranking Accounting or Finance Officer? | Directly Responsible for Accounting? | Appointed After the End of the Fiscal Year? |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| other | Doctor | SUPAPONG | CHANLONGBUTRA | President | M | 1,958 | 643 · Description: Thailand | Y | 2002-01-14T00:00 | Bachelor's degree | Medicine | 134 · Description: Health Care Services · 163 · Description: Leadership · 265 · Description: Governance/ Compliance · 151 · Description: Data Management · 117 · Description: Personal Products & Pharmaceuticals | Y | N | N | N |
| Mrs. | SOONTHREE | CHANLONGBUTRA | Chief Executive Officer | F | 1,959 | 643 · Description: Thailand | Y | 2002-01-14T00:00 | Honorary degree | Management | 142 · Description: Marketing · 156 · Description: Negotiation · 163 · Description: Leadership · 164 · Description: Strategic Management · 1683 · Description: Business Administration | N | N | N | N | |
| Mr. | MANIT | WONGPRISANLAK | Vice President of Sales and Marketing | M | 1,972 | 643 · Description: Thailand | Y | 2002-01-14T00:00 | Bachelor's degree | Business Administration | 148 · Description: Procurement · 156 · Description: Negotiation · 164 · Description: Strategic Management · 1683 · Description: Business Administration · 117 · Description: Personal Products & Pharmaceuticals | N | N | N | N | |
| Ms. | PRANGCHAI | CHANLONGBUTRA | Chief Financial Officer | F | 1,990 | 643 · Description: Thailand | Y | 2020-05-11T00:00 | Master's degree | Business Administration | 143 · Description: Accounting · 144 · Description: Finance · 1683 · Description: Business Administration · 166 · Description: Audit | N | Y | Y | N | |
| Ms. | PRAE | CHANLONGBUTRA | Chief Operation Officer | F | 1,987 | 643 · Description: Thailand | Y | 2025-08-09T00:00 | Master's degree | Business Administration | 142 · Description: Marketing · 155 · Description: Brand Management · 151 · Description: Data Management · 152 · Description: Data Analysis | N | N | N | N |
Executive Remuneration
Monetary Remuneration
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total remuneration of executive directors and executives (baht) | 29,703,809.01 | 33,449,289.24 | 34,185,689.55 |
| Total remuneration of executive directors (baht) | 0 | 0 | 0 |
| Total remuneration of executives (baht) | 29,703,809.01 | 33,449,289.24 | 34,185,689.55 |
Other Remuneration
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Company’s contribution to provident fund for executive directors and executives (Baht) | 1,913,328 | 2,119,975 | |
| Employee Stock Ownership Plan (ESOP) | 0 | 0 | 0 |
| Employee Joint Investment Program (EJIP) | 0 | 0 | 0 |
Remuneration or Benefits Payable to Executives
| Metric | Amount (Baht) |
|---|---|
| Outstanding remuneration or benefits of executive directors and executives in the past year (baht) | 0 |
| Estimated remuneration of executive directors and executives in the current year (baht) | 0 |
Remuneration Policy
Executive Remuneration Policy
The Board of Directors has appointed a Nomination and Compensation Committee to consider the remuneration policy for directors and senior executives to ensure appropriateness. The Committee will consider the directors' and executives' roles, responsibilities, knowledge, capabilities, performance, and benchmark against remuneration data from other companies in the same industry. The remuneration of directors is subject to the approval of the Board of Directors and the shareholders' meeting.
Was an Opinion Obtained from the Board and the Remuneration Committee?
Yes
Opinion of the Board and the Remuneration Committee
Consideration of Directors' and Executives' Compensation The Board of Directors will consider the duties and responsibilities of each director or executive, as well as their individual performance and the Company's overall performance. The compensation will be in line with market or industry rates. The remuneration of the Board of Directors must also be approved by the shareholders' meeting.
Employees
Employees by Department
| Department | Employees |
|---|---|
| Sales Department | 33 |
| Sales Department | 10 |
| Product Specialist Department | 3 |
| Accounting and Finance | 15 |
| Purchasing Department | 4 |
| Human Resources Department | 7 |
| Product Registration Department | 2 |
| Information Technology Department | 2 |
| Technical Department | 1 |
| Office of the Chief Executive Officer | 10 |
| Logistics and Transportation Department | 9 |
| New Product and Business Development Department | 0 |
| Retail and Online | 2 |
| Research, Development, and Design Department | 0 |
Any Significant Change in Headcount in the Past 3 Years?
No
Employee Remuneration
Nature of Employee Remuneration
The Company has established a policy to provide employees with fair and appropriate remuneration, taking into consideration each employee’s knowledge, competence, responsibilities, and performance, alongside the Company’s overall operating results. This is to ensure alignment with the Company’s business objectives and to promote effective work performance.
Employees of the Company receive compensation in both monetary and non-monetary forms.
Monetary compensation includes salary, bonus, overtime pay, commission, transportation allowance, and per diem. Significant non-monetary compensation includes participation in the provident fund.
In addition to various forms of compensation, the Company provides appropriate and comprehensive welfare benefits to support the quality of life of its executives and employees. These include group health insurance for executives and employees, participation in the Social Security Fund, and the Workmen’s Compensation Fund as required by law.
The Company provides employee uniform benefits, as well as financial assistance on various occasions, such as funeral assistance for employees’ parents and hospital visitation support for employees. In addition, the Company organizes activities to foster employee engagement and relationships, including annual company trips and seminars, periodic employee health check-ups, and educational scholarships for employees’ children.
Such welfare benefits reflect the Company’s commitment to providing comprehensive care for its employees in terms of health, social security, and family support. These initiatives form an important foundation for strengthening employee engagement and fostering sustainable growth together between employees and the organization.
Provident Fund
Does the Company Have a Provident Fund?
Yes
Provident Fund Policy
The company has established a provident fund for executives and employees to promote savings and provide financial security benefits, serving as financial support for employees upon retirement or termination of employment. The company places importance on selecting funds that adhere to the principles of institutional investors’ stewardship and responsible investment, taking into account environmental, social, and governance (ESG) factors.
The company has appointed TISCO Asset Management Company Limited as the fund manager of its provident fund to manage investments efficiently and transparently, in line with the objective of enhancing long-term financial security for employees.
Provident Fund Arrangements — Introduction
Enrollment in the provident fund is on a voluntary basis for employees under the fund's regulations. The company requires employees who are eligible to apply for membership in the fund to have worked for 1 year or more.
The Human Resources Department has communicated information regarding benefits, conditions, and savings guidelines under the provident fund to employees who are eligible to apply for membership. This is to enhance their understanding and encourage awareness of the importance of long-term financial planning.
However, the company's subsidiaries, namely The Parents Company Limited and TM Trading Company Limited, do not yet have a provident fund for employees.
Does the Fund Committee Follow the I Code?
Yes
Contribution Method and Rate
Employees may elect to contribute to the Fund at a rate ranging from 3–15% of their salary, based on their individual preference. The Company contributes at a rate of 3–10% of the employee’s salary, with the employer’s contribution rate determined in accordance with the employee’s length of service.
Policy for Employees Not in the Provident Fund
Automatic Enrolment
No
Encouraging Retirement Saving
No
Providing Investment Information
No
Other Measures
No
Auditors and Audit Fees
Auditors — Introduction
The Company has appointed auditors from M. R. & Associates Co., Ltd. which is an auditor approved by the Office of the Securities and Exchange Commission, as the Company's auditor.
The Company pays remuneration for financial statements audit during 2023 - 2025 as follows:
Year | Audit Fee (THB) |
2023 | 1,460,000 |
2024 | 1,500,000 |
2025 | 1,500,000 |
Other services (Non-Audit Fee)
-None-
How Audit Fees Are Reported
SEPERATE
Company Auditor and Fees
| Audit Firm | Address | Sub-district | District | Province | Postcode | Fax | Auditors | Audit Fee (Baht) | Any Non-audit Fee? |
|---|---|---|---|---|---|---|---|---|---|
| M.R. & ASSOCIATES COMPANY LIMITED | SUITE # 706, CHAOPHYA TOWER 89, SOI WAT SUAN PLU,NEW ROAD | BANG RAK | BANG RAK | Bangkok | 10500 | +66 2630 7506 | akadet@mrassociates.co.th · Title: 260 · Regis no: 5389 · Last name: PLIENSAKUL · First name: AKADET | 1,500,000 | N |
How Subsidiary Audit Information Is Reported
AUDITOR_AND_FEE
Subsidiary Auditors and Fees
| Audit Firm | Address | Sub-district | District | Province | Postcode | Fax | Auditors | Audit Fee (Baht) | Any Non-audit Fee? |
|---|---|---|---|---|---|---|---|---|---|
| M.R. & ASSOCIATES COMPANY LIMITED | SUITE # 706, CHAOPHYA TOWER 89, SOI WAT SUAN PLU,NEW ROAD | BANG RAK | BANG RAK | Bangkok | 10500 | +66 2630 7506 | akadet@mrassociates.co.th · Title: 260 · Regis no: 5389 · Last name: PLIENSAKUL · First name: AKADET | 140,000 | N |
Company Secretary and Other Assigned Persons
Company Secretary — Introduction
According to the requirements of Section 89/15 of the Public Limited Company Act B.E. 2535, the Board of Directors is required to appoint a company secretary to be responsible on behalf of the company or the Board of Directors. The meeting of the Board of Directors No. 1/2016 (the first meeting after the conversion to a public limited company) on March 31, 2016, resolved to appoint Ms. Supattra Kamkaew as the company secretary, with the following roles, duties, and responsibilities:
Prepare and keep the following documents:
(1) Register of Directors
(2) Notice of Meeting of the Board of Directors, Minutes of Meeting of the Board of Directors, and Annual Report of the Company.
(3) Notice of Meeting of Shareholders and Minutes of Meeting of Shareholders
Keep a report of conflicts of interest reported by directors or executives and send a copy of such report to the Chairman of the Board and the Chairman of the Audit Committee within seven business days from the date the Company receives the report.
Establish a system for keeping and maintaining documents and evidence related to the disclosure of the following information, including ensuring that such documents or evidence are kept correctly, completely, and verifiable for a period of not less than five years from the date of creation of such documents or information:
The keeping of the aforementioned documents and evidence shall include keeping by computer system or any other system that can be retrieved without alteration of the text.
(1) Providing information for the resolutions of the shareholders' meeting.
(2) Financial statements and reports on the financial position and performance of the Company or any other reports required to be disclosed under Sections 56, 57, 58, or 199 of the Securities and Exchange Act.
(3) The Company's opinion in the event of a tender offer for the Company's shares from the shareholders in general.
(4) Providing information or any other reports regarding the business that the Company prepares for disclosure to shareholders or the public as prescribed by the SEC.
Other acts as prescribed by the SEC.
Must perform duties with responsibility, prudence, and honesty, including compliance with the law, objectives, requirements of the Company, resolutions of the Board of Directors, and resolutions of the shareholders' meeting, and shall not commit any act that is detrimental or contrary to the interests of the Company in a material respect.
Must perform duties with the responsibility and care that a reasonable person in the same business would exercise under the same circumstances.
(1) The decision was made in good faith and on reasonable grounds that it is in the best interests of the Company.
(2) The decision was made on the basis of information that is honestly believed to be sufficient, and
(3) The decision was made without any direct or indirect interest in the matter being decided.
In the event that the company secretary vacates the office or is unable to perform his/her duties, the Board of Directors shall appoint a new company secretary within ninety days from the date the former company secretary vacates the office or is unable to perform his/her duties.
Principles of Conduct for the Company Secretary
The company secretary must perform his/her duties with responsibility, prudence, and honesty, and must comply with the rules, objectives, and requirements of the Company, the resolutions of the Board of Directors, and the resolutions of the shareholders.
1. Decisions must be made on the basis of information that is honestly believed to be sufficient.
2. The decision was made without any direct or indirect interest in the matter being decided.
3. Act honestly and in good faith in the best interests of the Company.
4. Act with a proper and appropriate purpose and shall not commit any act that is detrimental or contrary to the interests of the Company in a material respect.
5. Not taking advantage of the use of Company information learned, except for information that has already been disclosed to the public, or using the Company's assets or business opportunities in a manner that violates the principles or general practices prescribed by the SEC.
6. Not entering into any agreement or contract which may cause a conflict of interest with the Company, its employees, or customers, and which is contrary to the performance of his/her duties.
In the event that the company secretary vacates the office or is unable to perform his/her duties
Guidelines for practice in the event that the company secretary vacates the office or is unable to perform his/her duties are as follows:
1. Have the Board of Directors appoint a new company secretary within 90 days from the date the former company secretary vacates the office or is unable to perform his/her duties.
2. Authorize the Board of Directors to assign one of the directors to act in the place of the company secretary during the period in which the company secretary vacates the office or is unable to perform his/her duties.
3. Have the Chairman of the Board notify the name of the company secretary to the Securities and Exchange Commission within 14 days from the date of appointment of the person responsible for such position to notify the Securities and Exchange Commission of the place where the documents are kept.
Company Secretary
| Title | First Name | Last Name | Telephone | |
|---|---|---|---|---|
| Ms. | Supattra | Kamkaew | info@technomedical.co.th | 029336112 |
Chief Accountant
| Title | First Name | Last Name | Telephone | |
|---|---|---|---|---|
| Ms. | Prangchai | Chanlongbutra | prangchai@technomedical.co.th | 029336112 |
Head of Internal Audit — Introduction
The company has established a systematic internal audit process by utilizing the services of an external audit firm to oversee various aspects of operations and report audit results directly to the Audit Committee. The internal auditor is responsible for advising, auditing, and evaluating the adequacy and effectiveness of the company's internal control system, risk management system, and corporate governance processes to ensure that these systems are appropriately established, effective, and achieve their stated objectives.
In 2021, the company appointed Dharmniti Internal Audit Co., Ltd., an external audit firm (Outsource), to serve as the company's internal audit unit to continuously audit the internal control system and assess the adequacy of the company's internal control system up to the present. Ms. Prangchai Chanlongbutra, Chief Financial Officer, acts as the coordinator with the internal auditor.
The internal auditor will present the internal audit report to the Audit Committee meeting and prepare an annual internal audit plan for the Audit Committee's consideration and approval. This is to serve as a guideline for monitoring, auditing, and evaluating the accuracy and completeness of operations in accordance with the company's established plans and policies. The company has continuously improved and developed its internal control system.
The Audit Committee is of the opinion that Dharmniti Internal Audit Co., Ltd., which serves as the company's internal audit unit, is qualified to perform its duties due to its experience and expertise in auditing listed companies, as well as its independence and reliability in performing its work.
Head of Internal Audit
| Title | First Name | Last Name | Telephone | |
|---|---|---|---|---|
| Ms. | Somcharee | Kawkomdee | somcharee@dir.co.th | 02-5960500 ต่อ 503 |
Investor Relations Contact
Does the Company Have an Investor Relations Contact?
Yes
Investor Relations Contacts
| Title | First Name | Last Name | Telephone | |
|---|---|---|---|---|
| Ms. | Supattra | Kamkaew | info@technomedical.co.th | 02-933-6112 |
Head of Investor Relations — Introduction
The company has assigned the Company Secretary to perform and be responsible for investor relations duties, with the role of providing information and communicating with shareholders, investors, securities analysts, and the general public. Those wishing to contact can inquire for information via email at info@technomedical.co.th or by phone at 0-2933-6112 ext. 8401 and 8402, as well as through the company's website at www.technomedical.co.th
Regarding investor relations activities, the company regularly participated in the "Opportunity Day' event organized by the Stock Exchange of Thailand every quarter. In 2025, the company participated in this event 4 times online to report and present the company's operating results to shareholders, investors, and securities analysts.
Furthermore, the company regularly prepares a "Listed Company Snapshot" document every quarter to disseminate important and useful information to shareholders, investors, and the general public.
Representatives in Thailand (Foreign Companies)
Does the Company Have Representatives in Thailand?
No
Audit Committee Members Who Left During the Year
Audit Committee Members Who Left
| Title | First Name | Last Name | Position | Gender | Year of Birth | Nationality | Resident in Thailand? | Appointment Date | Highest Education | Field of Study | Has Accounting or Financial Expertise? | Meetings Held | Meetings Attended | Meeting Allowance (Baht) | Total Remuneration (Baht) | Non-monetary Remuneration | Date of Leaving | Replaced By — Title | Replaced By — Title, Please Specify | Replaced By — First Name | Replaced By — Last Name | Date the Replacement Took Office |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mrs. | RATANA | ANUPASANANT | Audit committee | F | 1,955 | 643 · Description: Thailand | Y | 2016-02-04T00:00 | Master's degree | Business Administration | Y | 1 | 1 | 11,000 | 11,000 | 0 | 2025-05-09T00:00 | other | Dr. | ANIWAT | SIRIDEJVARAVONG | 2025-05-10T00:00 |
Executive Committee Members Who Left During the Year
Executive Committee Members Who Left
| Title | Title — Please Specify | First Name | Last Name | Position | Gender | Year of Birth | Nationality | Resident in Thailand? | Appointment Date | Highest Education | Field of Study | Meetings Held | Meetings Attended | Meeting Allowance (Baht) | Other Remuneration (Baht) | Total Remuneration (Baht) | Non-monetary Remuneration | Date of Leaving | Replaced By — Title | Replaced By — First Name | Replaced By — Last Name | Date the Replacement Took Office |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| other | Doctor | SUPAPONG | CHANLONGBUTRA | Chairman of the executive committee | M | 1,958 | 643 · Description: Thailand | Y | 2016-03-31T00:00 | Bachelor's degree | Medicine | 6 | 5 | 0 | 0 | 0 | 0 | 2025-08-09T00:00 | Ms. | PRAE | CHANLONGBUTRA | 2025-08-09T00:00 |
| Ms. | PRAE | CHANLONGBUTRA | Member of the executive committee | F | 1,987 | 643 · Description: Thailand | Y | 2020-05-11T00:00 | Master's degree | Business Administration | 2025-02-14T00:00 |
Other Subcommittees — Members Who Left During the Year
Other Subcommittees with Members Who Left
| Subcommittee Name | Type of Subcommittee | Roles, Duties and Responsibilities | Link to the Charter | Meetings Held | Subcommittee Remuneration | Members Who Left |
|---|---|---|---|---|---|---|
| Nomination & Compensation Committee | 3093 · Description: Director and executive nomination · 3094 · Description: Remuneration | The Nomination and Remuneration Committee, in its first meeting of 2023, reviewed its scope of authority and responsibilities and resolved to maintain the existing scope as follows:
Nomination
1. Establish appropriate director nomination procedures that align with the nature and operations of the organization, including defining desired qualifications and expertise.
2. Identify director candidates when vacancies arise or terms expire. This may involve considering existing directors for reappointment, accepting nominations from shareholders, engaging external search firms, considering individuals recommended by the Board of Directors, or requesting nominations from individual directors.
3. Review the qualifications of nominated candidates and shortlist those who meet the established criteria.
4. Ensure that nominated individuals satisfy legal and regulatory requirements.
5. Approach shortlisted candidates to confirm their willingness to serve as directors if appointed by the shareholders.
6. Submit the final list of candidates to the Board of Directors for consideration and inclusion in the notice of the Annual General Meeting for shareholder appointment.
7. Identify and recommend candidates for senior management positions as mandated by the Board of Directors.
Remuneration
1. Review and establish appropriate remuneration policies for directors and senior management, ensuring alignment with industry benchmarks, company performance, and the responsibilities, expertise, and experience required for each role. This includes considering the fairness and competitiveness of the remuneration structure.
2. Review and assess all forms of remuneration, including salaries, performance-based incentives, and meeting attendance fees, taking into account industry practices, company performance and size, and the responsibilities, knowledge, skills, and experience of directors and senior management.
3. Establish performance evaluation criteria for the Chief Executive Officer, subcommittee chairs, and senior management as directed by the Board of Directors.
4. Determine the annual remuneration for directors, the Chairman of the Board, the Chief Executive Officer, and senior management based on the established remuneration policies. Submit recommendations for the remuneration of the Chairman of the Board, the Chief Executive Officer, and senior management to the Board of Directors for approval. Submit recommendations for director remuneration to the Board of Directors for proposal to the shareholders at the Annual General Meeting.
5. Review and provide recommendations on proposed employee and director stock option plans, ensuring fairness to shareholders and incentivizing long-term value creation while attracting and retaining talent. | https://www.technomedical.co.th/charter-remuneration | 4 | 92000.0 · Meeting allowance: 92000.0 · Other remuneration: 0.0 | 262 · Last name: ANUPASANANT · Position: 37 · First name: RATANA · Acting date: 2025-05-10 · Total meeting: 2 · Meeting allowance: 32000.0 · Total remuneration: 32000.0 · Replacement director: Title: 262 · Description: Mrs. · Last name: CHUASAI · First name: CHUASAI · Total meeting attendance: 2 · Non monetary remuneration: 0 · Replacement director title: 262 · Resignation effective date: 2025-05-09 · Replacement director last name: CHUASAI · Replacement director first name: CHUASAI · 262 · Last name: CHANLONGBUTRA · Position: 39 · First name: SOONTHREE · Total meeting: 4 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 4 · Non monetary remuneration: 0 · 263 · Last name: LEELAYOUTHAYOTIN · Position: 39 · First name: LACKANA · Total meeting: 4 · Title other name: Dr. · Meeting allowance: 44000.0 · Other remuneration: 0.0 · Total remuneration: 44000.0 · Total meeting attendance: 4 · Non monetary remuneration: 0 · 260 · Last name: CHUASAI · Position: 37 · First name: JUMPHOT · Total meeting: 1 · Meeting allowance: 16000.0 · Other remuneration: 0.0 · Total remuneration: 16000.0 · Total meeting attendance: 1 · Non monetary remuneration: 0 |
| Risk Management Committee | 3092 · Description: Risk management | 1. Establish a risk management policy and framework for presentation to the Board of Directors in accordance with the risk management guidelines of the Stock Exchange of Thailand and the Institute of Internal Auditors of Thailand.
2. Develop strategies in alignment with the risk management policy to enable the assessment, monitoring, and control of each type of risk within acceptable levels, ensuring the participation of all departments in risk management and control.
3. Assess risks at the enterprise level, define risk mitigation methods to maintain risks within acceptable levels, and oversee the implementation of risk management in accordance with the defined methods.
4. Review and enhance the risk management policy to ensure its adequacy and effectiveness in mitigating risks.
5. Possess the authority to summon relevant individuals for clarification or to assign and define roles that empower employees at all levels to manage risks appropriately, and to report to the Risk Management Committee to ensure the achievement of risk management objectives.
6. Report risk management outcomes to the Executive Committee and the Audit Committee for regular quarterly presentations to the Board of Directors.
7. Develop a risk management manual.
8. Identify various risks, analyze and assess potential risks, including trends that may impact the company.
9. Develop action plans to prevent or mitigate risks.
10. Evaluate and report on risk management performance.
11. Implement an integrated risk management system by connecting information systems.
12. Perform other tasks as deemed appropriate by the Board of Directors. | https://www.technomedical.co.th/charter-risk | 4 | 0.0 · Meeting allowance: 0.0 · Other remuneration: 0.0 | 262 · Last name: CHANLONGBUTRA · Position: 39 · First name: SOONTHREE · Acting date: 2025-08-09 · Total meeting: 3 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Replacement director: Title: 262 · Description: Mrs. · Last name: CHANLONGBUTRA · First name: CHANLONGBUTRA · Total meeting attendance: 3 · Non monetary remuneration: 0 · Replacement director title: 262 · Resignation effective date: 2025-08-09 · Replacement director last name: CHANLONGBUTRA · Replacement director first name: CHANLONGBUTRA · 260 · Last name: WONGPRISANLAK · Position: 37 · First name: MANIT · Total meeting: 4 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 4 · Non monetary remuneration: 0 · 261 · Last name: CHANLONGBUTRA · Position: 39 · First name: PRAE · Resignation effective date: 2025-04-18 · 261 · Last name: CHANLONGBUTRA · Position: 39 · First name: PRANGCHAI · Total meeting: 4 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 4 · Non monetary remuneration: 0 · 261 · Last name: CHANLONGBUTRA · Position: 39 · First name: PRAE · Total meeting: 2 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 2 · Non monetary remuneration: 0 · 263 · Last name: SIRIDEJVARAVONG · Position: 39 · First name: ANIWAT · Total meeting: 1 · Title other name: Dr. · Meeting allowance: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 1 · Non monetary remuneration: 0 |
| Sustainable Development Committee | 3096 · Description: Sustainability development | 1. Review sustainability policies and development goals to align with the company's objectives, adhering to sustainable business principles that consider stakeholders in environmental, social, and governance (ESG) aspects.
2. Communicate policies and practices, monitor progress in policy implementation, and evaluate outcomes.
3. Support, promote, and consider plans and budgets for the company's sustainability activities.
4. Report material and beneficial operational results to the Board of Directors regularly.
5. Perform other duties as assigned by the Board of Directors. | https://www.technomedical.co.th/charter-sustainability | 1 | 0.0 · Meeting allowance: 0.0 · Other remuneration: 0.0 | 261 · Last name: CHANLONGBUTRA · Position: 37 · First name: PRANGCHAI · Acting date: 2025-08-09 · Total meeting: 0 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Replacement director: Title: 261 · Description: Ms. · Last name: SIRIDEJVARAVONG · First name: SIRIDEJVARAVONG · Total meeting attendance: 0 · Non monetary remuneration: 0 · Replacement director title: 261 · Resignation effective date: 2025-08-09 · Replacement director last name: SIRIDEJVARAVONG · Replacement director first name: SIRIDEJVARAVONG · 263 · Last name: SIRIDEJVARAVONG · Position: 37 · First name: ANIWAT · Total meeting: 1 · Title other name: Dr. · Meeting allowance: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 1 · Non monetary remuneration: 0 · 261 · Last name: CHANLONGBUTRA · Position: 39 · First name: PRAE · Total meeting: 1 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 1 · Non monetary remuneration: 0 |

